| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fragile X Syndrome | 78 | 2022 | 148 | 7.490 |
Why?
|
| Fragile X Mental Retardation Protein | 56 | 2022 | 125 | 4.730 |
Why?
|
| RNA-Binding Proteins | 42 | 2022 | 984 | 3.150 |
Why?
|
| X Chromosome | 42 | 2001 | 337 | 2.200 |
Why?
|
| Cytochrome P-450 Enzyme System | 16 | 2020 | 201 | 2.150 |
Why?
|
| Tremor | 6 | 2022 | 128 | 1.890 |
Why?
|
| Trinucleotide Repeat Expansion | 11 | 2021 | 131 | 1.860 |
Why?
|
| Ataxia | 6 | 2022 | 175 | 1.850 |
Why?
|
| Hepatitis C, Chronic | 8 | 2022 | 451 | 1.760 |
Why?
|
| Nerve Tissue Proteins | 37 | 2016 | 1491 | 1.680 |
Why?
|
| Antiviral Agents | 13 | 2022 | 1234 | 1.670 |
Why?
|
| Genetics, Medical | 5 | 2021 | 143 | 1.410 |
Why?
|
| Human Genetics | 2 | 2019 | 5 | 1.320 |
Why?
|
| Evolution, Molecular | 23 | 2020 | 834 | 1.170 |
Why?
|
| Hepatitis C | 5 | 2022 | 524 | 1.150 |
Why?
|
| Multigene Family | 18 | 2020 | 425 | 1.150 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 37 | 2011 | 358 | 1.140 |
Why?
|
| Hepacivirus | 9 | 2022 | 398 | 1.130 |
Why?
|
| Incontinentia Pigmenti | 11 | 2006 | 15 | 1.080 |
Why?
|
| Genetic Variation | 14 | 2021 | 2089 | 1.070 |
Why?
|
| Genome, Fungal | 7 | 2019 | 54 | 1.000 |
Why?
|
| Molecular Sequence Data | 65 | 2015 | 6062 | 0.980 |
Why?
|
| Behavior, Animal | 11 | 2020 | 711 | 0.920 |
Why?
|
| Phylogeny | 27 | 2020 | 826 | 0.910 |
Why?
|
| Circadian Rhythm | 6 | 2014 | 330 | 0.860 |
Why?
|
| Chromosome Mapping | 26 | 2005 | 1464 | 0.850 |
Why?
|
| Saccharomyces cerevisiae | 8 | 2021 | 620 | 0.830 |
Why?
|
| Drosophila Proteins | 8 | 2014 | 857 | 0.820 |
Why?
|
| Biological Evolution | 11 | 2019 | 278 | 0.800 |
Why?
|
| Genetic Diseases, Inborn | 5 | 2021 | 442 | 0.780 |
Why?
|
| Drosophila | 8 | 2019 | 839 | 0.770 |
Why?
|
| Developmental Disabilities | 3 | 2021 | 669 | 0.770 |
Why?
|
| RNA, Messenger | 18 | 2017 | 6129 | 0.770 |
Why?
|
| Secondary Metabolism | 5 | 2020 | 5 | 0.760 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2021 | 63 | 0.760 |
Why?
|
| Biomedical Research | 2 | 2019 | 807 | 0.750 |
Why?
|
| Trinucleotide Repeats | 11 | 2013 | 106 | 0.740 |
Why?
|
| Vibrio | 2 | 2011 | 6 | 0.720 |
Why?
|
| Chromosomes, Human, X | 4 | 2009 | 191 | 0.700 |
Why?
|
| Microsatellite Repeats | 5 | 2013 | 576 | 0.700 |
Why?
|
| Genome | 9 | 2019 | 678 | 0.680 |
Why?
|
| Sequence Analysis, DNA | 21 | 2016 | 2480 | 0.680 |
Why?
|
| Disease Models, Animal | 24 | 2022 | 7218 | 0.680 |
Why?
|
| Animals | 113 | 2022 | 59486 | 0.670 |
Why?
|
| Haplotypes | 7 | 2002 | 866 | 0.670 |
Why?
|
| Long-Term Potentiation | 4 | 2014 | 176 | 0.670 |
Why?
|
| Base Sequence | 51 | 2014 | 4886 | 0.660 |
Why?
|
| Mycobacterium | 4 | 2020 | 56 | 0.650 |
Why?
|
| Mutation | 35 | 2021 | 15167 | 0.650 |
Why?
|
| Alleles | 21 | 2021 | 2434 | 0.610 |
Why?
|
| Ribavirin | 4 | 2021 | 178 | 0.610 |
Why?
|
| Drug Users | 1 | 2017 | 18 | 0.590 |
Why?
|
| Transcriptome | 4 | 2021 | 1863 | 0.590 |
Why?
|
| Genetic Drift | 4 | 2019 | 30 | 0.580 |
Why?
|
| Genome, Plant | 7 | 2021 | 24 | 0.580 |
Why?
|
| Bacterial Proteins | 5 | 2020 | 1032 | 0.570 |
Why?
|
| Genes | 16 | 2007 | 480 | 0.570 |
Why?
|
| Genetic Research | 1 | 2017 | 63 | 0.560 |
Why?
|
| Neurons | 11 | 2021 | 2290 | 0.550 |
Why?
|
| Trans-Activators | 10 | 2014 | 1557 | 0.540 |
Why?
|
| Mice | 60 | 2022 | 34391 | 0.540 |
Why?
|
| Awards and Prizes | 1 | 2017 | 98 | 0.530 |
Why?
|
| Gene Editing | 1 | 2018 | 217 | 0.520 |
Why?
|
| Ganoderma | 1 | 2015 | 1 | 0.520 |
Why?
|
| Mental Retardation, X-Linked | 2 | 2009 | 94 | 0.520 |
Why?
|
| Uridine Monophosphate | 1 | 2015 | 18 | 0.520 |
Why?
|
| Hippocampus | 8 | 2011 | 921 | 0.520 |
Why?
|
| Genome, Human | 12 | 2004 | 1868 | 0.500 |
Why?
|
| Humans | 177 | 2022 | 262269 | 0.500 |
Why?
|
| Genome, Insect | 4 | 2021 | 98 | 0.500 |
Why?
|
| Hypothyroidism | 2 | 2015 | 205 | 0.500 |
Why?
|
| Mice, Knockout | 26 | 2021 | 5672 | 0.500 |
Why?
|
| Cloning, Molecular | 19 | 2008 | 1208 | 0.500 |
Why?
|
| Nuclear Proteins | 13 | 2021 | 3317 | 0.490 |
Why?
|
| Periodicals as Topic | 1 | 2019 | 337 | 0.490 |
Why?
|
| Linkage Disequilibrium | 6 | 2006 | 462 | 0.490 |
Why?
|
| Hemolysin Proteins | 2 | 2011 | 27 | 0.480 |
Why?
|
| Amino Acid Sequence | 26 | 2019 | 4231 | 0.470 |
Why?
|
| Protein Biosynthesis | 9 | 2022 | 888 | 0.430 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2011 | 192 | 0.430 |
Why?
|
| Societies, Medical | 1 | 2019 | 1341 | 0.430 |
Why?
|
| Stillbirth | 1 | 2013 | 81 | 0.430 |
Why?
|
| Intellectual Disability | 6 | 2019 | 1025 | 0.420 |
Why?
|
| Models, Genetic | 11 | 2019 | 1111 | 0.420 |
Why?
|
| Exons | 19 | 2019 | 1325 | 0.410 |
Why?
|
| Nervous System Diseases | 2 | 2013 | 499 | 0.400 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2012 | 58 | 0.400 |
Why?
|
| Spinocerebellar Ataxias | 4 | 2013 | 232 | 0.400 |
Why?
|
| Eye | 5 | 2011 | 299 | 0.400 |
Why?
|
| Polymerase Chain Reaction | 25 | 2014 | 3189 | 0.400 |
Why?
|
| Genetic Therapy | 3 | 2018 | 1601 | 0.400 |
Why?
|
| Gene Expression | 14 | 2019 | 3563 | 0.390 |
Why?
|
| Diabetes, Gestational | 1 | 2013 | 105 | 0.390 |
Why?
|
| Imidazoles | 3 | 2021 | 1003 | 0.390 |
Why?
|
| Male | 100 | 2022 | 123347 | 0.380 |
Why?
|
| Selection, Genetic | 6 | 2018 | 189 | 0.380 |
Why?
|
| Mice, Inbred C57BL | 16 | 2020 | 6925 | 0.380 |
Why?
|
| DNA Repeat Expansion | 2 | 2013 | 64 | 0.370 |
Why?
|
| Cyanobacteria | 2 | 2020 | 21 | 0.370 |
Why?
|
| Pan troglodytes | 5 | 2006 | 206 | 0.360 |
Why?
|
| Patient Selection | 2 | 2017 | 2063 | 0.360 |
Why?
|
| Streptomyces | 2 | 2020 | 16 | 0.360 |
Why?
|
| Pedigree | 23 | 2012 | 1884 | 0.350 |
Why?
|
| Bacillus | 2 | 2020 | 37 | 0.350 |
Why?
|
| Chromosomes, Fungal | 7 | 2009 | 44 | 0.350 |
Why?
|
| Phenotype | 16 | 2021 | 6255 | 0.350 |
Why?
|
| DNA | 24 | 2004 | 2683 | 0.340 |
Why?
|
| Glucose | 2 | 2014 | 1247 | 0.340 |
Why?
|
| Synapses | 2 | 2014 | 512 | 0.340 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2012 | 4556 | 0.340 |
Why?
|
| Hominidae | 5 | 2003 | 37 | 0.340 |
Why?
|
| History, 21st Century | 3 | 2021 | 442 | 0.340 |
Why?
|
| I-kappa B Kinase | 5 | 2006 | 249 | 0.330 |
Why?
|
| Myotonic Dystrophy | 5 | 2013 | 151 | 0.320 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2020 | 337 | 0.320 |
Why?
|
| History, 20th Century | 3 | 2021 | 575 | 0.320 |
Why?
|
| DNA-Binding Proteins | 8 | 2014 | 4787 | 0.320 |
Why?
|
| RNA-Induced Silencing Complex | 2 | 2007 | 26 | 0.320 |
Why?
|
| Secretin | 3 | 2008 | 25 | 0.320 |
Why?
|
| Sofosbuvir | 3 | 2021 | 22 | 0.320 |
Why?
|
| Muscle, Skeletal | 4 | 2019 | 1277 | 0.310 |
Why?
|
| Fungal Proteins | 5 | 2019 | 254 | 0.310 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2009 | 245 | 0.310 |
Why?
|
| Female | 77 | 2021 | 142305 | 0.300 |
Why?
|
| Chromosome Deletion | 4 | 2007 | 1002 | 0.300 |
Why?
|
| Oomycetes | 2 | 2018 | 2 | 0.300 |
Why?
|
| Protein C | 1 | 2007 | 32 | 0.290 |
Why?
|
| Sequence Homology, Amino Acid | 11 | 2011 | 995 | 0.290 |
Why?
|
| Bacterial Toxins | 1 | 2008 | 228 | 0.280 |
Why?
|
| Gene Deletion | 4 | 2011 | 1440 | 0.280 |
Why?
|
| Gene Duplication | 6 | 2018 | 421 | 0.280 |
Why?
|
| Animals, Genetically Modified | 6 | 2019 | 405 | 0.280 |
Why?
|
| Cell Line | 16 | 2014 | 5071 | 0.260 |
Why?
|
| Cytoskeletal Proteins | 3 | 2004 | 493 | 0.260 |
Why?
|
| Primates | 3 | 2003 | 127 | 0.260 |
Why?
|
| Genes, Fungal | 3 | 2018 | 84 | 0.250 |
Why?
|
| Mice, Transgenic | 11 | 2019 | 4125 | 0.250 |
Why?
|
| Chromosomes, Mammalian | 1 | 2004 | 60 | 0.250 |
Why?
|
| Alternative Splicing | 3 | 1999 | 581 | 0.250 |
Why?
|
| Transcription Factors | 10 | 2016 | 5253 | 0.250 |
Why?
|
| Muscular Atrophy, Spinal | 3 | 1993 | 45 | 0.250 |
Why?
|
| Adaptation, Physiological | 4 | 2016 | 361 | 0.240 |
Why?
|
| Genetic Fitness | 2 | 2016 | 39 | 0.240 |
Why?
|
| Carbamates | 2 | 2015 | 77 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2004 | 104 | 0.240 |
Why?
|
| Genetic Linkage | 12 | 2005 | 506 | 0.240 |
Why?
|
| Chlamydomonas reinhardtii | 3 | 2015 | 7 | 0.230 |
Why?
|
| Genomics | 7 | 2019 | 2744 | 0.230 |
Why?
|
| Purkinje Cells | 3 | 2014 | 142 | 0.230 |
Why?
|
| Trisomy | 1 | 2004 | 230 | 0.230 |
Why?
|
| Helminths | 1 | 2004 | 37 | 0.230 |
Why?
|
| Fear | 4 | 2006 | 252 | 0.230 |
Why?
|
| Carrier Proteins | 5 | 2001 | 2022 | 0.230 |
Why?
|
| Host-Parasite Interactions | 2 | 2021 | 65 | 0.230 |
Why?
|
| Proteins | 7 | 2001 | 1953 | 0.230 |
Why?
|
| Insect Proteins | 3 | 2020 | 91 | 0.220 |
Why?
|
| Genetics, Population | 2 | 2022 | 243 | 0.220 |
Why?
|
| Terpenes | 1 | 2023 | 34 | 0.220 |
Why?
|
| Plankton | 1 | 2022 | 2 | 0.220 |
Why?
|
| RNA, Messenger, Stored | 1 | 2022 | 6 | 0.220 |
Why?
|
| Genes, Plant | 4 | 2020 | 44 | 0.220 |
Why?
|
| Anti-Infective Agents | 1 | 2007 | 447 | 0.220 |
Why?
|
| Insecticide Resistance | 2 | 2020 | 28 | 0.220 |
Why?
|
| Spermatids | 1 | 2022 | 42 | 0.220 |
Why?
|
| Recombination, Genetic | 7 | 2004 | 612 | 0.220 |
Why?
|
| Blotting, Southern | 10 | 2002 | 399 | 0.210 |
Why?
|
| Gene Frequency | 10 | 2005 | 1165 | 0.210 |
Why?
|
| Diterpenes | 1 | 2023 | 112 | 0.210 |
Why?
|
| Gene Amplification | 5 | 1995 | 730 | 0.210 |
Why?
|
| Fishes | 2 | 2013 | 46 | 0.210 |
Why?
|
| Antibiosis | 1 | 2021 | 15 | 0.210 |
Why?
|
| Period Circadian Proteins | 2 | 2014 | 52 | 0.210 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2021 | 5538 | 0.210 |
Why?
|
| Down Syndrome | 1 | 2004 | 223 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2001 | 640 | 0.200 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2007 | 596 | 0.200 |
Why?
|
| Genotype | 8 | 2021 | 4104 | 0.200 |
Why?
|
| Ectopic Gene Expression | 1 | 2021 | 4 | 0.200 |
Why?
|
| Gene Expression Regulation | 8 | 2016 | 4026 | 0.200 |
Why?
|
| Drug Therapy, Combination | 4 | 2021 | 2325 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2011 | 3632 | 0.200 |
Why?
|
| Muscidae | 1 | 2021 | 2 | 0.200 |
Why?
|
| Valine | 3 | 2021 | 176 | 0.200 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2021 | 50 | 0.200 |
Why?
|
| Chromosomes, Artificial, Yeast | 7 | 2000 | 39 | 0.200 |
Why?
|
| Florida | 2 | 2019 | 113 | 0.200 |
Why?
|
| Insect Control | 1 | 2021 | 13 | 0.200 |
Why?
|
| NF-kappa B | 2 | 2006 | 1551 | 0.200 |
Why?
|
| Fructokinases | 1 | 2021 | 8 | 0.200 |
Why?
|
| Gonadotropins | 1 | 2021 | 49 | 0.200 |
Why?
|
| Genes, Neoplasm | 1 | 2002 | 327 | 0.190 |
Why?
|
| Pharmacology, Clinical | 1 | 2021 | 10 | 0.190 |
Why?
|
| Ecosystem | 3 | 2020 | 114 | 0.190 |
Why?
|
| Sepsis | 1 | 2007 | 657 | 0.190 |
Why?
|
| Membrane Proteins | 4 | 2022 | 2811 | 0.190 |
Why?
|
| Receptors, Metabotropic Glutamate | 3 | 2011 | 63 | 0.190 |
Why?
|
| Quinoxalines | 2 | 2021 | 95 | 0.190 |
Why?
|
| ARNTL Transcription Factors | 2 | 2013 | 57 | 0.190 |
Why?
|
| Oocytes | 2 | 2021 | 412 | 0.190 |
Why?
|
| Disease Resistance | 1 | 2020 | 24 | 0.190 |
Why?
|
| Cultural Characteristics | 1 | 2001 | 70 | 0.190 |
Why?
|
| Adult | 21 | 2022 | 78181 | 0.190 |
Why?
|
| Minisatellite Repeats | 3 | 2002 | 51 | 0.190 |
Why?
|
| Zea mays | 1 | 2020 | 46 | 0.190 |
Why?
|
| Indians, North American | 1 | 2001 | 87 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2002 | 402 | 0.190 |
Why?
|
| Coleoptera | 2 | 2018 | 18 | 0.190 |
Why?
|
| Mammals | 2 | 2008 | 368 | 0.190 |
Why?
|
| Hepatocytes | 3 | 2011 | 346 | 0.180 |
Why?
|
| Chromosome Fragility | 3 | 1995 | 32 | 0.180 |
Why?
|
| Dosage Compensation, Genetic | 5 | 2005 | 63 | 0.180 |
Why?
|
| Codon | 1 | 2000 | 242 | 0.180 |
Why?
|
| Conserved Sequence | 6 | 2018 | 469 | 0.180 |
Why?
|
| Neural Inhibition | 2 | 2013 | 147 | 0.180 |
Why?
|
| Heteroptera | 1 | 2020 | 10 | 0.180 |
Why?
|
| Prosencephalon | 1 | 2020 | 43 | 0.180 |
Why?
|
| Databases, Factual | 2 | 2007 | 2236 | 0.180 |
Why?
|
| Spermatogenesis | 1 | 2022 | 308 | 0.180 |
Why?
|
| Sensory Gating | 2 | 2011 | 14 | 0.180 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2020 | 130 | 0.180 |
Why?
|
| Machine Learning | 1 | 2022 | 322 | 0.180 |
Why?
|
| Algorithms | 5 | 2022 | 3890 | 0.180 |
Why?
|
| DNA Helicases | 2 | 2002 | 435 | 0.180 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2019 | 5 | 0.180 |
Why?
|
| Sequence Homology, Nucleic Acid | 8 | 2014 | 348 | 0.180 |
Why?
|
| Cytochrome P450 Family 51 | 1 | 2019 | 1 | 0.180 |
Why?
|
| Basidiomycota | 1 | 2019 | 9 | 0.180 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2018 | 1557 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 4 | 2 | 1998 | 108 | 0.170 |
Why?
|
| Hemolysis | 2 | 2011 | 126 | 0.170 |
Why?
|
| Serotonin | 1 | 2021 | 260 | 0.170 |
Why?
|
| Auditory Cortex | 1 | 2020 | 38 | 0.170 |
Why?
|
| Algal Proteins | 2 | 2010 | 5 | 0.170 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2022 | 1485 | 0.170 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2019 | 6 | 0.170 |
Why?
|
| Sulfonamides | 3 | 2021 | 1826 | 0.170 |
Why?
|
| Uracil | 2 | 2021 | 64 | 0.170 |
Why?
|
| Treatment Failure | 1 | 2022 | 1393 | 0.170 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 590 | 0.170 |
Why?
|
| Autistic Disorder | 1 | 2002 | 323 | 0.170 |
Why?
|
| Brain | 12 | 2013 | 4097 | 0.170 |
Why?
|
| Fireflies | 1 | 2018 | 2 | 0.170 |
Why?
|
| Sesquiterpenes | 1 | 2019 | 69 | 0.170 |
Why?
|
| Physician's Role | 1 | 2021 | 241 | 0.170 |
Why?
|
| Genes, Recessive | 2 | 2019 | 200 | 0.170 |
Why?
|
| Saccharum | 1 | 2018 | 10 | 0.170 |
Why?
|
| Intermediate Filament Proteins | 2 | 1990 | 82 | 0.170 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 2019 | 86 | 0.170 |
Why?
|
| Luciferases, Firefly | 1 | 2018 | 39 | 0.170 |
Why?
|
| California | 1 | 2019 | 209 | 0.170 |
Why?
|
| Conidiobolus | 1 | 2018 | 1 | 0.160 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 148 | 0.160 |
Why?
|
| Academies and Institutes | 1 | 2019 | 95 | 0.160 |
Why?
|
| Chromosome Inversion | 2 | 2001 | 182 | 0.160 |
Why?
|
| Ophthalmoplegia | 1 | 2019 | 79 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 12 | 3 | 2006 | 185 | 0.160 |
Why?
|
| Sequence Tagged Sites | 3 | 1997 | 33 | 0.160 |
Why?
|
| Pyrrolidines | 2 | 2017 | 113 | 0.160 |
Why?
|
| Molecular Sequence Annotation | 5 | 2018 | 201 | 0.160 |
Why?
|
| Cytosine | 3 | 2013 | 141 | 0.160 |
Why?
|
| Benzimidazoles | 2 | 2021 | 428 | 0.160 |
Why?
|
| Polyploidy | 1 | 2018 | 73 | 0.160 |
Why?
|
| Restriction Mapping | 11 | 1997 | 260 | 0.160 |
Why?
|
| Whole Genome Sequencing | 1 | 2020 | 336 | 0.160 |
Why?
|
| Organ Specificity | 7 | 2017 | 694 | 0.160 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2018 | 85 | 0.160 |
Why?
|
| Cosmids | 5 | 1996 | 40 | 0.160 |
Why?
|
| Cytochrome P-450 CYP2C19 | 1 | 2017 | 22 | 0.160 |
Why?
|
| Pharmacogenomic Testing | 1 | 2017 | 43 | 0.160 |
Why?
|
| Pharmacogenomic Variants | 1 | 2017 | 29 | 0.150 |
Why?
|
| Taxus | 1 | 2017 | 1 | 0.150 |
Why?
|
| Prasugrel Hydrochloride | 1 | 2017 | 25 | 0.150 |
Why?
|
| Dictyostelium | 1 | 2019 | 124 | 0.150 |
Why?
|
| Introns | 6 | 2013 | 430 | 0.150 |
Why?
|
| Luminescent Proteins | 1 | 2018 | 289 | 0.150 |
Why?
|
| In Situ Hybridization, Fluorescence | 8 | 2011 | 2232 | 0.150 |
Why?
|
| Young Adult | 7 | 2021 | 21493 | 0.150 |
Why?
|
| Heterozygote | 6 | 2021 | 1015 | 0.150 |
Why?
|
| Reflex, Startle | 4 | 2011 | 65 | 0.150 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2017 | 24 | 0.150 |
Why?
|
| In Vitro Techniques | 4 | 2016 | 1613 | 0.150 |
Why?
|
| Drosophila melanogaster | 6 | 2022 | 828 | 0.150 |
Why?
|
| Hemiptera | 1 | 2016 | 9 | 0.150 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2014 | 584 | 0.150 |
Why?
|
| Viral Load | 3 | 2017 | 492 | 0.150 |
Why?
|
| Interleukins | 2 | 2012 | 327 | 0.150 |
Why?
|
| Anilides | 2 | 2021 | 267 | 0.140 |
Why?
|
| X Chromosome Inactivation | 2 | 2007 | 74 | 0.140 |
Why?
|
| DNA Mutational Analysis | 12 | 2002 | 2279 | 0.140 |
Why?
|
| Membrane Transport Proteins | 2 | 2007 | 245 | 0.140 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 245 | 0.140 |
Why?
|
| Models, Statistical | 2 | 2018 | 1177 | 0.140 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2016 | 27 | 0.140 |
Why?
|
| Neurodegenerative Diseases | 2 | 2011 | 266 | 0.140 |
Why?
|
| Hypocreales | 1 | 2016 | 2 | 0.140 |
Why?
|
| Spinocerebellar Degenerations | 4 | 2005 | 21 | 0.140 |
Why?
|
| Ligand-Gated Ion Channels | 1 | 2016 | 1 | 0.140 |
Why?
|
| Anaplasma phagocytophilum | 1 | 2016 | 2 | 0.140 |
Why?
|
| Virus Replication | 3 | 2011 | 706 | 0.140 |
Why?
|
| Signal Transduction | 9 | 2022 | 11972 | 0.140 |
Why?
|
| Nematoda | 1 | 2016 | 17 | 0.140 |
Why?
|
| Simeprevir | 1 | 2016 | 9 | 0.140 |
Why?
|
| Bacteriophage T7 | 1 | 2015 | 4 | 0.140 |
Why?
|
| Arachnid Vectors | 1 | 2016 | 10 | 0.140 |
Why?
|
| Sequence Deletion | 5 | 2006 | 874 | 0.140 |
Why?
|
| Immunity, Innate | 1 | 2020 | 677 | 0.140 |
Why?
|
| Gene Library | 10 | 2000 | 293 | 0.140 |
Why?
|
| Ixodes | 1 | 2016 | 14 | 0.140 |
Why?
|
| Genetic Markers | 9 | 2002 | 972 | 0.140 |
Why?
|
| Founder Effect | 1 | 2015 | 42 | 0.140 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2020 | 430 | 0.140 |
Why?
|
| Peptides | 2 | 2021 | 1476 | 0.140 |
Why?
|
| Transcription, Genetic | 11 | 2011 | 3127 | 0.130 |
Why?
|
| Deoxyribonuclease I | 1 | 1995 | 65 | 0.130 |
Why?
|
| Interferon-alpha | 5 | 2011 | 889 | 0.130 |
Why?
|
| Administration, Oral | 2 | 2021 | 1554 | 0.130 |
Why?
|
| Prenatal Diagnosis | 2 | 2017 | 585 | 0.130 |
Why?
|
| Acidosis | 1 | 2016 | 117 | 0.130 |
Why?
|
| Huntington Disease | 2 | 1993 | 135 | 0.130 |
Why?
|
| Transcription Initiation Site | 2 | 2013 | 52 | 0.130 |
Why?
|
| Fats | 1 | 2014 | 16 | 0.130 |
Why?
|
| Salvia miltiorrhiza | 1 | 2014 | 5 | 0.130 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 2014 | 18 | 0.130 |
Why?
|
| Cohort Studies | 5 | 2019 | 9283 | 0.130 |
Why?
|
| DNA Primers | 7 | 2001 | 1395 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1996 | 253 | 0.130 |
Why?
|
| Protein Conformation | 1 | 2018 | 1257 | 0.130 |
Why?
|
| Human Genome Project | 3 | 2001 | 64 | 0.120 |
Why?
|
| Glucagon | 1 | 2014 | 196 | 0.120 |
Why?
|
| Receptors, GABA-A | 1 | 2015 | 79 | 0.120 |
Why?
|
| Zika Virus Infection | 1 | 2017 | 167 | 0.120 |
Why?
|
| Middle Aged | 17 | 2021 | 86548 | 0.120 |
Why?
|
| Macrocyclic Compounds | 1 | 2014 | 10 | 0.120 |
Why?
|
| Memory, Long-Term | 1 | 2014 | 39 | 0.120 |
Why?
|
| Genetic Complementation Test | 2 | 2011 | 126 | 0.120 |
Why?
|
| Retroelements | 2 | 2011 | 47 | 0.120 |
Why?
|
| Time Factors | 6 | 2019 | 12985 | 0.120 |
Why?
|
| Houseflies | 1 | 2014 | 4 | 0.120 |
Why?
|
| Muscles | 1 | 1995 | 416 | 0.120 |
Why?
|
| Receptors, AMPA | 1 | 2014 | 70 | 0.120 |
Why?
|
| Species Specificity | 5 | 2018 | 774 | 0.120 |
Why?
|
| Genome, Bacterial | 3 | 2020 | 200 | 0.120 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2017 | 445 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 4 | 2002 | 3076 | 0.120 |
Why?
|
| Aged | 14 | 2021 | 70370 | 0.120 |
Why?
|
| Motor Activity | 4 | 2008 | 692 | 0.120 |
Why?
|
| Lactams, Macrocyclic | 3 | 2021 | 90 | 0.120 |
Why?
|
| Atherosclerosis | 1 | 2022 | 936 | 0.120 |
Why?
|
| Cyclopropanes | 3 | 2021 | 88 | 0.120 |
Why?
|
| Computational Biology | 6 | 2018 | 1270 | 0.120 |
Why?
|
| Neuronal Plasticity | 3 | 2006 | 306 | 0.120 |
Why?
|
| Nelumbo | 1 | 2013 | 2 | 0.120 |
Why?
|
| Ritonavir | 1 | 2014 | 67 | 0.120 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2014 | 126 | 0.110 |
Why?
|
| Ribosomes | 1 | 2014 | 147 | 0.110 |
Why?
|
| Symbiosis | 1 | 2014 | 78 | 0.110 |
Why?
|
| Bulbo-Spinal Atrophy, X-Linked | 1 | 2013 | 2 | 0.110 |
Why?
|
| Cryptochromes | 2 | 2014 | 14 | 0.110 |
Why?
|
| Patient Safety | 1 | 2019 | 649 | 0.110 |
Why?
|
| Population Surveillance | 2 | 2013 | 628 | 0.110 |
Why?
|
| RNA, Viral | 5 | 2021 | 667 | 0.110 |
Why?
|
| Proline | 3 | 2021 | 129 | 0.110 |
Why?
|
| Nucleotides | 1 | 1993 | 163 | 0.110 |
Why?
|
| Models, Molecular | 1 | 2018 | 1740 | 0.110 |
Why?
|
| Insect Vectors | 1 | 2014 | 110 | 0.110 |
Why?
|
| Larva | 2 | 2016 | 274 | 0.110 |
Why?
|
| Astrocytes | 1 | 2016 | 365 | 0.110 |
Why?
|
| Frontotemporal Dementia | 1 | 2013 | 39 | 0.110 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2011 | 255 | 0.110 |
Why?
|
| DNA, Complementary | 5 | 1999 | 870 | 0.110 |
Why?
|
| Haploinsufficiency | 1 | 2014 | 292 | 0.110 |
Why?
|
| Endometrial Ablation Techniques | 1 | 2012 | 1 | 0.110 |
Why?
|
| Reishi | 1 | 2012 | 2 | 0.110 |
Why?
|
| Dendrites | 3 | 2009 | 197 | 0.110 |
Why?
|
| Nitriles | 1 | 2017 | 904 | 0.110 |
Why?
|
| Muscle Strength | 1 | 2013 | 106 | 0.110 |
Why?
|
| Amino Acid Motifs | 3 | 2019 | 394 | 0.110 |
Why?
|
| Plant Proteins | 4 | 2017 | 136 | 0.110 |
Why?
|
| Transfection | 6 | 2009 | 2934 | 0.110 |
Why?
|
| Sequence Alignment | 5 | 2017 | 843 | 0.110 |
Why?
|
| DNA-Directed DNA Polymerase | 2 | 1994 | 182 | 0.110 |
Why?
|
| Blotting, Northern | 6 | 2001 | 672 | 0.110 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2012 | 29 | 0.110 |
Why?
|
| Tuberculosis | 1 | 2019 | 555 | 0.110 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2017 | 347 | 0.110 |
Why?
|
| Microscopy, Electron, Scanning | 3 | 2007 | 219 | 0.110 |
Why?
|
| Point Mutation | 1 | 1995 | 769 | 0.110 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2017 | 425 | 0.110 |
Why?
|
| Plants | 3 | 2023 | 63 | 0.100 |
Why?
|
| Bryopsida | 2 | 2011 | 2 | 0.100 |
Why?
|
| Amygdala | 1 | 2013 | 127 | 0.100 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2012 | 100 | 0.100 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 624 | 0.100 |
Why?
|
| Pregnancy | 7 | 2017 | 7549 | 0.100 |
Why?
|
| Drug Combinations | 3 | 2021 | 621 | 0.100 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 2 | 2011 | 14 | 0.100 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2011 | 32 | 0.100 |
Why?
|
| Nutrition Surveys | 1 | 2013 | 299 | 0.100 |
Why?
|
| Menorrhagia | 1 | 2012 | 66 | 0.100 |
Why?
|
| Analysis of Variance | 3 | 2018 | 2312 | 0.100 |
Why?
|
| Talin | 1 | 2011 | 14 | 0.100 |
Why?
|
| Selaginellaceae | 1 | 2011 | 2 | 0.100 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 3 | 1996 | 29 | 0.100 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 154 | 0.100 |
Why?
|
| Desmoplakins | 1 | 2011 | 22 | 0.100 |
Why?
|
| Cells, Cultured | 10 | 2019 | 5597 | 0.100 |
Why?
|
| Muscle Proteins | 1 | 1995 | 551 | 0.100 |
Why?
|
| Acoustic Stimulation | 4 | 2020 | 118 | 0.100 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2013 | 158 | 0.100 |
Why?
|
| Infant, Premature | 1 | 2016 | 791 | 0.100 |
Why?
|
| Lymphoproliferative Disorders | 4 | 1997 | 367 | 0.100 |
Why?
|
| Methylation | 7 | 1994 | 591 | 0.100 |
Why?
|
| RNA | 7 | 2013 | 1010 | 0.100 |
Why?
|
| Models, Theoretical | 4 | 2021 | 787 | 0.100 |
Why?
|
| DNA Probes | 6 | 1993 | 217 | 0.100 |
Why?
|
| Patch-Clamp Techniques | 2 | 2009 | 389 | 0.100 |
Why?
|
| Oligonucleotide Probes | 4 | 2002 | 129 | 0.100 |
Why?
|
| Sheep | 1 | 2011 | 257 | 0.100 |
Why?
|
| Sleep Wake Disorders | 1 | 2014 | 351 | 0.100 |
Why?
|
| Nerve Degeneration | 1 | 2012 | 149 | 0.090 |
Why?
|
| Gorilla gorilla | 2 | 2002 | 15 | 0.090 |
Why?
|
| United States | 7 | 2019 | 15581 | 0.090 |
Why?
|
| Electrophysiology | 2 | 2008 | 333 | 0.090 |
Why?
|
| In Situ Hybridization | 3 | 2009 | 1033 | 0.090 |
Why?
|
| DNA Methylation | 3 | 2013 | 2671 | 0.090 |
Why?
|
| Chimera | 2 | 2018 | 144 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 2015 | 523 | 0.090 |
Why?
|
| Recombinant Proteins | 3 | 2007 | 2914 | 0.090 |
Why?
|
| Gene Expression Profiling | 4 | 2020 | 5155 | 0.090 |
Why?
|
| Nerve Net | 1 | 2013 | 257 | 0.090 |
Why?
|
| Erythrocytes | 1 | 2011 | 339 | 0.090 |
Why?
|
| Genetic Engineering | 2 | 2016 | 287 | 0.090 |
Why?
|
| Argonaute Proteins | 2 | 2007 | 40 | 0.090 |
Why?
|
| Mutagenesis, Insertional | 2 | 2008 | 218 | 0.090 |
Why?
|
| Nectria | 1 | 2009 | 1 | 0.090 |
Why?
|
| Polymorphism, Genetic | 7 | 2015 | 1448 | 0.090 |
Why?
|
| Learning | 2 | 2011 | 407 | 0.090 |
Why?
|
| Adolescent | 8 | 2021 | 31238 | 0.090 |
Why?
|
| Hospitalization | 1 | 2019 | 2119 | 0.090 |
Why?
|
| Centromere | 3 | 2005 | 97 | 0.090 |
Why?
|
| Intelligence | 2 | 1994 | 127 | 0.090 |
Why?
|
| Chromosomes, Human | 2 | 1997 | 292 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 2 | 2013 | 693 | 0.090 |
Why?
|
| RNA Transport | 1 | 2009 | 14 | 0.090 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2009 | 19 | 0.090 |
Why?
|
| Anisomycin | 1 | 2009 | 11 | 0.090 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 2009 | 24 | 0.090 |
Why?
|
| Self Report | 1 | 2013 | 777 | 0.090 |
Why?
|
| Germ-Line Mutation | 1 | 1994 | 1047 | 0.080 |
Why?
|
| DNA, Bacterial | 1 | 2011 | 559 | 0.080 |
Why?
|
| Aspergillus nidulans | 1 | 2008 | 28 | 0.080 |
Why?
|
| Cell Line, Transformed | 2 | 2002 | 391 | 0.080 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2009 | 71 | 0.080 |
Why?
|
| Endosonography | 1 | 2012 | 536 | 0.080 |
Why?
|
| Age Factors | 4 | 2016 | 5384 | 0.080 |
Why?
|
| Biophysics | 1 | 2009 | 111 | 0.080 |
Why?
|
| Major Histocompatibility Complex | 2 | 1986 | 94 | 0.080 |
Why?
|
| Introduced Species | 2 | 2020 | 22 | 0.080 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 29996 | 0.080 |
Why?
|
| Translocation, Genetic | 4 | 2018 | 1244 | 0.080 |
Why?
|
| 2-Naphthylamine | 2 | 2021 | 6 | 0.080 |
Why?
|
| Liver | 3 | 2008 | 2904 | 0.080 |
Why?
|
| Blotting, Western | 5 | 2007 | 3529 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2017 | 788 | 0.080 |
Why?
|
| Flavoproteins | 1 | 2008 | 33 | 0.080 |
Why?
|
| Gene Transfer, Horizontal | 2 | 2020 | 57 | 0.080 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 2008 | 24 | 0.080 |
Why?
|
| Salmo salar | 1 | 2008 | 3 | 0.080 |
Why?
|
| Fish Diseases | 1 | 2008 | 9 | 0.080 |
Why?
|
| Vibrio Infections | 1 | 2008 | 11 | 0.080 |
Why?
|
| Operon | 1 | 2008 | 54 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2013 | 6103 | 0.080 |
Why?
|
| Tissue Donors | 1 | 2012 | 790 | 0.080 |
Why?
|
| Cricetinae | 7 | 1994 | 702 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 2992 | 0.080 |
Why?
|
| Homeostasis | 1 | 2013 | 941 | 0.080 |
Why?
|
| Registries | 1 | 2016 | 2188 | 0.080 |
Why?
|
| Liver Transplantation | 2 | 2016 | 1106 | 0.080 |
Why?
|
| Genetic Carrier Screening | 5 | 1994 | 92 | 0.080 |
Why?
|
| Mice, Inbred Strains | 4 | 1999 | 518 | 0.080 |
Why?
|
| Treatment Outcome | 6 | 2021 | 33028 | 0.080 |
Why?
|
| Expressed Sequence Tags | 2 | 2006 | 101 | 0.080 |
Why?
|
| Electric Stimulation | 1 | 2009 | 427 | 0.080 |
Why?
|
| Genetic Testing | 4 | 2021 | 1587 | 0.070 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2008 | 151 | 0.070 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2012 | 826 | 0.070 |
Why?
|
| Models, Biological | 2 | 2016 | 3242 | 0.070 |
Why?
|
| Cell Cycle Proteins | 3 | 2008 | 2053 | 0.070 |
Why?
|
| Genes, Bacterial | 1 | 2008 | 238 | 0.070 |
Why?
|
| Pregnancy Outcome | 3 | 2017 | 638 | 0.070 |
Why?
|
| APACHE | 1 | 2007 | 93 | 0.070 |
Why?
|
| Epilepsy, Reflex | 1 | 2006 | 6 | 0.070 |
Why?
|
| Neural Pathways | 1 | 2009 | 297 | 0.070 |
Why?
|
| Terminal Repeat Sequences | 1 | 2006 | 27 | 0.070 |
Why?
|
| Chromosomes | 2 | 1987 | 242 | 0.070 |
Why?
|
| Receptors, Gastrointestinal Hormone | 1 | 2006 | 10 | 0.070 |
Why?
|
| Cerebellum | 2 | 2013 | 445 | 0.070 |
Why?
|
| Recurrence | 2 | 2012 | 4784 | 0.070 |
Why?
|
| Hybrid Cells | 6 | 1995 | 111 | 0.070 |
Why?
|
| Catheter Ablation | 1 | 2012 | 624 | 0.070 |
Why?
|
| Iduronate Sulfatase | 2 | 1997 | 12 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2013 | 1129 | 0.070 |
Why?
|
| Cell Death | 1 | 2009 | 672 | 0.070 |
Why?
|
| MicroRNAs | 3 | 2011 | 2955 | 0.070 |
Why?
|
| Purine-Pyrimidine Metabolism, Inborn Errors | 1 | 1986 | 2 | 0.070 |
Why?
|
| Conditioning, Classical | 2 | 2006 | 68 | 0.070 |
Why?
|
| Limb Salvage | 1 | 2007 | 163 | 0.070 |
Why?
|
| Information Services | 1 | 2006 | 50 | 0.070 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2007 | 137 | 0.070 |
Why?
|
| Interpersonal Relations | 1 | 2008 | 293 | 0.070 |
Why?
|
| Ataxin-10 | 1 | 2005 | 19 | 0.070 |
Why?
|
| Conditioning, Eyelid | 1 | 2005 | 2 | 0.070 |
Why?
|
| Chromosome Aberrations | 3 | 2001 | 1957 | 0.070 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2005 | 14 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2016 | 7241 | 0.070 |
Why?
|
| Liver Cirrhosis | 1 | 2012 | 945 | 0.070 |
Why?
|
| Agar | 2 | 2016 | 25 | 0.070 |
Why?
|
| Myocytes, Cardiac | 1 | 2011 | 785 | 0.060 |
Why?
|
| Multiple Organ Failure | 1 | 2007 | 178 | 0.060 |
Why?
|
| Transformation, Genetic | 2 | 1987 | 57 | 0.060 |
Why?
|
| Retroviridae | 1 | 1986 | 323 | 0.060 |
Why?
|
| DNA Transposable Elements | 3 | 2011 | 221 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 2 | 2009 | 1487 | 0.060 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 443 | 0.060 |
Why?
|
| Protein Isoforms | 3 | 2009 | 836 | 0.060 |
Why?
|
| Chromosome Fragile Sites | 2 | 1995 | 38 | 0.060 |
Why?
|
| Crosses, Genetic | 1 | 2004 | 239 | 0.060 |
Why?
|
| Gene Expression Regulation, Plant | 2 | 2017 | 93 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 619 | 0.060 |
Why?
|
| Sequence Homology | 1 | 2004 | 70 | 0.060 |
Why?
|
| Culture Media | 2 | 2016 | 320 | 0.060 |
Why?
|
| Social Behavior | 1 | 2006 | 308 | 0.060 |
Why?
|
| Tetraodontiformes | 1 | 2004 | 1 | 0.060 |
Why?
|
| Lower Extremity | 1 | 2007 | 300 | 0.060 |
Why?
|
| Urochordata | 1 | 2004 | 4 | 0.060 |
Why?
|
| Caenorhabditis | 1 | 2004 | 6 | 0.060 |
Why?
|
| Testis | 4 | 2005 | 716 | 0.060 |
Why?
|
| Interferon Type I | 1 | 2005 | 250 | 0.060 |
Why?
|
| Hindlimb | 1 | 2004 | 107 | 0.060 |
Why?
|
| Logistic Models | 2 | 2012 | 3450 | 0.060 |
Why?
|
| Tissue Distribution | 3 | 2002 | 877 | 0.060 |
Why?
|
| Receptors, Estrogen | 1 | 2011 | 2085 | 0.060 |
Why?
|
| Biological Transport | 2 | 2022 | 598 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2007 | 746 | 0.060 |
Why?
|
| Infant, Newborn | 5 | 2017 | 8225 | 0.060 |
Why?
|
| Cercopithecidae | 1 | 2003 | 10 | 0.060 |
Why?
|
| Age of Onset | 1 | 2005 | 826 | 0.060 |
Why?
|
| Cebidae | 1 | 2003 | 28 | 0.060 |
Why?
|
| RNA, Plant | 2 | 2014 | 23 | 0.060 |
Why?
|
| Neurofilament Proteins | 2 | 1995 | 31 | 0.060 |
Why?
|
| Europe | 2 | 2005 | 646 | 0.060 |
Why?
|
| Karyotyping | 4 | 1998 | 1017 | 0.060 |
Why?
|
| Counseling | 1 | 2006 | 383 | 0.060 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2006 | 483 | 0.060 |
Why?
|
| Marine Biology | 1 | 2022 | 3 | 0.050 |
Why?
|
| Longevity | 1 | 2004 | 149 | 0.050 |
Why?
|
| Skull | 1 | 2004 | 224 | 0.050 |
Why?
|
| Craniofacial Abnormalities | 1 | 2004 | 237 | 0.050 |
Why?
|
| Diffusion | 1 | 2022 | 89 | 0.050 |
Why?
|
| Proportional Hazards Models | 2 | 2012 | 5009 | 0.050 |
Why?
|
| Oculocerebrorenal Syndrome | 2 | 1992 | 8 | 0.050 |
Why?
|
| Pan paniscus | 1 | 2002 | 5 | 0.050 |
Why?
|
| Mosaicism | 3 | 1995 | 272 | 0.050 |
Why?
|
| Protein Binding | 2 | 2020 | 3438 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2003 | 218 | 0.050 |
Why?
|
| Plant Breeding | 1 | 2021 | 13 | 0.050 |
Why?
|
| Poaceae | 1 | 2021 | 11 | 0.050 |
Why?
|
| Triticum | 1 | 2021 | 32 | 0.050 |
Why?
|
| Fluorenes | 1 | 2021 | 17 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2004 | 270 | 0.050 |
Why?
|
| Gene Rearrangement | 3 | 2000 | 784 | 0.050 |
Why?
|
| Hormones | 1 | 2023 | 267 | 0.050 |
Why?
|
| Drug Resistance | 3 | 2017 | 588 | 0.050 |
Why?
|
| Genetic Vectors | 2 | 1990 | 1681 | 0.050 |
Why?
|
| Computer Simulation | 2 | 2017 | 1531 | 0.050 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2001 | 129 | 0.050 |
Why?
|
| Electrophoresis, Capillary | 1 | 2021 | 31 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2012 | 6223 | 0.050 |
Why?
|
| Sustained Virologic Response | 1 | 2021 | 57 | 0.050 |
Why?
|
| Fructose Metabolism, Inborn Errors | 1 | 2021 | 1 | 0.050 |
Why?
|
| Binding Sites | 2 | 2018 | 2170 | 0.050 |
Why?
|
| Benzofurans | 1 | 2021 | 38 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2022 | 107 | 0.050 |
Why?
|
| Oligonucleotides | 2 | 2013 | 227 | 0.050 |
Why?
|
| HEK293 Cells | 2 | 2019 | 1498 | 0.050 |
Why?
|
| Anemia | 1 | 2007 | 690 | 0.050 |
Why?
|
| Survival Rate | 2 | 2007 | 12239 | 0.050 |
Why?
|
| Pyridines | 1 | 2008 | 1243 | 0.050 |
Why?
|
| Receptors, Serotonin | 1 | 2021 | 45 | 0.050 |
Why?
|
| Genotyping Techniques | 1 | 2021 | 166 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 3 | 1994 | 257 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 2504 | 0.050 |
Why?
|
| Retrospective Studies | 5 | 2018 | 38022 | 0.050 |
Why?
|
| Chromosome Breakage | 2 | 1998 | 226 | 0.050 |
Why?
|
| Gene Products, rev | 1 | 2000 | 10 | 0.050 |
Why?
|
| Gene Targeting | 1 | 2002 | 293 | 0.050 |
Why?
|
| Epilepsy | 2 | 2006 | 881 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 76 | 0.050 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 1 | 2000 | 7 | 0.050 |
Why?
|
| Texas | 4 | 2018 | 6308 | 0.050 |
Why?
|
| Chromosome Banding | 2 | 1998 | 254 | 0.050 |
Why?
|
| Genome Size | 1 | 2020 | 17 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2001 | 345 | 0.050 |
Why?
|
| United Kingdom | 1 | 2021 | 257 | 0.050 |
Why?
|
| Ataxia Telangiectasia | 1 | 2000 | 62 | 0.050 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2022 | 200 | 0.050 |
Why?
|
| Mucopolysaccharidosis II | 2 | 1997 | 11 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2016 | 5568 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 5339 | 0.050 |
Why?
|
| Gamma Rhythm | 1 | 2020 | 13 | 0.050 |
Why?
|
| Cell Nucleolus | 1 | 2000 | 90 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2000 | 170 | 0.050 |
Why?
|
| Myocardium | 2 | 2004 | 1295 | 0.050 |
Why?
|
| Smoking Cessation | 1 | 2006 | 727 | 0.050 |
Why?
|
| Mental Disorders | 2 | 2000 | 870 | 0.040 |
Why?
|
| Magnoliopsida | 2 | 2011 | 11 | 0.040 |
Why?
|
| Risk Factors | 7 | 2017 | 17622 | 0.040 |
Why?
|
| Receptor, Metabotropic Glutamate 5 | 2 | 2011 | 19 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2006 | 790 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2019 | 1642 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 10067 | 0.040 |
Why?
|
| Plasmids | 2 | 2013 | 833 | 0.040 |
Why?
|
| Infertility, Male | 1 | 2022 | 296 | 0.040 |
Why?
|
| Memory Disorders | 1 | 2002 | 297 | 0.040 |
Why?
|
| Sex Chromosome Aberrations | 3 | 1993 | 49 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 7793 | 0.040 |
Why?
|
| Biosynthetic Pathways | 1 | 2019 | 47 | 0.040 |
Why?
|
| Chromosomes, Plant | 1 | 2018 | 6 | 0.040 |
Why?
|
| Karyopherins | 1 | 2000 | 135 | 0.040 |
Why?
|
| Guanine Nucleotides | 1 | 1998 | 22 | 0.040 |
Why?
|
| Proteome | 3 | 2011 | 563 | 0.040 |
Why?
|
| Sorghum | 1 | 2018 | 3 | 0.040 |
Why?
|
| Hydrodynamics | 1 | 2018 | 18 | 0.040 |
Why?
|
| Antigens, Neoplasm | 2 | 2005 | 1505 | 0.040 |
Why?
|
| Reproduction | 1 | 2021 | 253 | 0.040 |
Why?
|
| Cell Division | 2 | 2018 | 2467 | 0.040 |
Why?
|
| Pongo pygmaeus | 1 | 1998 | 6 | 0.040 |
Why?
|
| Dendritic Spines | 2 | 2011 | 59 | 0.040 |
Why?
|
| Mixed Function Oxygenases | 1 | 1998 | 64 | 0.040 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2000 | 427 | 0.040 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2020 | 358 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2007 | 2633 | 0.040 |
Why?
|
| Hydrogen Bonding | 1 | 2018 | 128 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2018 | 80 | 0.040 |
Why?
|
| Base Composition | 2 | 2009 | 91 | 0.040 |
Why?
|
| Ligands | 1 | 2021 | 992 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 87 | 0.040 |
Why?
|
| Aminoisobutyric Acids | 1 | 2017 | 9 | 0.040 |
Why?
|
| Situs Inversus | 1 | 1997 | 27 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 4323 | 0.040 |
Why?
|
| Heme | 1 | 2018 | 79 | 0.040 |
Why?
|
| Chromosome Duplication | 1 | 2018 | 157 | 0.040 |
Why?
|
| Adrenoleukodystrophy | 1 | 1997 | 8 | 0.040 |
Why?
|
| Data Mining | 1 | 2018 | 88 | 0.040 |
Why?
|
| Biomechanical Phenomena | 1 | 2018 | 340 | 0.040 |
Why?
|
| Plant Viruses | 1 | 2016 | 6 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1998 | 290 | 0.040 |
Why?
|
| Ribonuclease III | 2 | 2011 | 182 | 0.040 |
Why?
|
| Trees | 1 | 2016 | 15 | 0.040 |
Why?
|
| Chromosome Walking | 2 | 1995 | 4 | 0.040 |
Why?
|
| Temperature | 1 | 2018 | 508 | 0.040 |
Why?
|
| Metabolomics | 1 | 2020 | 476 | 0.040 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1996 | 25 | 0.040 |
Why?
|
| Jews | 1 | 1997 | 58 | 0.040 |
Why?
|
| Child | 5 | 2014 | 29065 | 0.040 |
Why?
|
| Adenine Nucleotides | 1 | 1998 | 351 | 0.040 |
Why?
|
| Forecasting | 2 | 2001 | 695 | 0.040 |
Why?
|
| Hylobates | 1 | 1996 | 11 | 0.040 |
Why?
|
| 5-Methylcytosine | 2 | 2013 | 55 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 1083 | 0.040 |
Why?
|
| Cycloheximide | 1 | 2016 | 96 | 0.040 |
Why?
|
| Dinucleoside Phosphates | 1 | 1996 | 19 | 0.040 |
Why?
|
| Ataxins | 3 | 2005 | 91 | 0.040 |
Why?
|
| COS Cells | 2 | 2011 | 375 | 0.030 |
Why?
|
| Creatine | 1 | 1996 | 61 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2009 | 662 | 0.030 |
Why?
|
| Gene Pool | 1 | 2015 | 7 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 541 | 0.030 |
Why?
|
| DNA Replication | 2 | 2000 | 746 | 0.030 |
Why?
|
| Pharmacogenetics | 1 | 2017 | 253 | 0.030 |
Why?
|
| Leucine | 1 | 2017 | 352 | 0.030 |
Why?
|
| Neoplasms | 1 | 2002 | 15180 | 0.030 |
Why?
|
| Lyme Disease | 1 | 2016 | 34 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2020 | 893 | 0.030 |
Why?
|
| Estrogen Antagonists | 1 | 2016 | 183 | 0.030 |
Why?
|
| Travel | 1 | 2017 | 197 | 0.030 |
Why?
|
| Muscular Dystrophies | 1 | 1995 | 51 | 0.030 |
Why?
|
| Amino Acids | 2 | 2014 | 727 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 4 | 1997 | 82 | 0.030 |
Why?
|
| Pregnanolone | 1 | 2015 | 7 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2002 | 2804 | 0.030 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2015 | 11 | 0.030 |
Why?
|
| Child Behavior Disorders | 1 | 1996 | 69 | 0.030 |
Why?
|
| Thyrotropin | 1 | 2015 | 117 | 0.030 |
Why?
|
| DNA Restriction Enzymes | 2 | 1986 | 115 | 0.030 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2003 | 640 | 0.030 |
Why?
|
| Xenopus laevis | 1 | 2016 | 268 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 11572 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2015 | 101 | 0.030 |
Why?
|
| Thyroxine | 1 | 2015 | 116 | 0.030 |
Why?
|
| Pyramidal Cells | 1 | 2016 | 170 | 0.030 |
Why?
|
| Ethidium | 1 | 1994 | 11 | 0.030 |
Why?
|
| Lymphocytes | 2 | 1996 | 1227 | 0.030 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2017 | 186 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 2011 | 591 | 0.030 |
Why?
|
| 5' Untranslated Regions | 1 | 2014 | 93 | 0.030 |
Why?
|
| Macromolecular Substances | 3 | 1995 | 294 | 0.030 |
Why?
|
| Laboratories | 1 | 2015 | 145 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 673 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2017 | 12923 | 0.030 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2014 | 110 | 0.030 |
Why?
|
| Fathers | 1 | 1994 | 68 | 0.030 |
Why?
|
| Brain Chemistry | 2 | 2006 | 145 | 0.030 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2015 | 72 | 0.030 |
Why?
|
| Terminator Regions, Genetic | 1 | 2013 | 8 | 0.030 |
Why?
|
| Fibroblasts | 2 | 2000 | 1642 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 526 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 2013 | 117 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2000 | 1063 | 0.030 |
Why?
|
| Uncoupling Protein 2 | 1 | 2013 | 26 | 0.030 |
Why?
|
| Infant | 4 | 2014 | 13285 | 0.030 |
Why?
|
| Vitis | 1 | 2013 | 14 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 315 | 0.030 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2013 | 48 | 0.030 |
Why?
|
| Action Potentials | 1 | 2016 | 562 | 0.030 |
Why?
|
| Proteomics | 1 | 2020 | 1386 | 0.030 |
Why?
|
| Adaptation, Biological | 1 | 2013 | 49 | 0.030 |
Why?
|
| Immunohistochemistry | 4 | 2009 | 7545 | 0.030 |
Why?
|
| Cancer Care Facilities | 1 | 2018 | 882 | 0.030 |
Why?
|
| Vertebrates | 1 | 2013 | 68 | 0.030 |
Why?
|
| Contig Mapping | 2 | 2005 | 61 | 0.030 |
Why?
|
| Chick Embryo | 1 | 2013 | 244 | 0.030 |
Why?
|
| Repressor Proteins | 2 | 2014 | 1663 | 0.030 |
Why?
|
| Genes, Homeobox | 1 | 2013 | 147 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2017 | 6900 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2000 | 1826 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 14914 | 0.030 |
Why?
|
| Motor Neurons | 1 | 2013 | 139 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2013 | 248 | 0.030 |
Why?
|
| Phospholipase A2 Inhibitors | 1 | 2012 | 4 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2013 | 245 | 0.030 |
Why?
|
| Mutation Rate | 1 | 2013 | 222 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2016 | 875 | 0.030 |
Why?
|
| Disease Progression | 2 | 2018 | 6694 | 0.030 |
Why?
|
| Syndrome | 1 | 1995 | 1351 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2016 | 1327 | 0.030 |
Why?
|
| DEAD Box Protein 58 | 1 | 2011 | 14 | 0.030 |
Why?
|
| Ion Channels | 1 | 2013 | 212 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2013 | 346 | 0.030 |
Why?
|
| Placenta | 1 | 1996 | 519 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2018 | 9195 | 0.030 |
Why?
|
| Nucleotide Mapping | 1 | 1991 | 24 | 0.030 |
Why?
|
| Penetrance | 1 | 2012 | 126 | 0.030 |
Why?
|
| Costameres | 1 | 2011 | 1 | 0.030 |
Why?
|
| Chlamydomonas | 1 | 2011 | 8 | 0.030 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1991 | 68 | 0.020 |
Why?
|
| Myofibrils | 1 | 2011 | 31 | 0.020 |
Why?
|
| Desmosomes | 1 | 2011 | 28 | 0.020 |
Why?
|
| Sarcomeres | 1 | 2011 | 43 | 0.020 |
Why?
|
| Intermediate Filaments | 1 | 2011 | 27 | 0.020 |
Why?
|
| Extremities | 1 | 2013 | 301 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 4903 | 0.020 |
Why?
|
| Spinal Cord | 1 | 1995 | 691 | 0.020 |
Why?
|
| CpG Islands | 2 | 2006 | 631 | 0.020 |
Why?
|
| Interferon-beta | 1 | 2011 | 102 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2017 | 1207 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 642 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2013 | 225 | 0.020 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1992 | 243 | 0.020 |
Why?
|
| Gene Dosage | 3 | 1994 | 830 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2013 | 4042 | 0.020 |
Why?
|
| Interferons | 1 | 2012 | 289 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 766 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2014 | 548 | 0.020 |
Why?
|
| RNA, Heterogeneous Nuclear | 1 | 1990 | 3 | 0.020 |
Why?
|
| Skin | 1 | 1996 | 1260 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 6047 | 0.020 |
Why?
|
| RNA Editing | 1 | 2011 | 92 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2013 | 464 | 0.020 |
Why?
|
| Pigments, Biological | 1 | 2010 | 12 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2013 | 373 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2011 | 154 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2011 | 242 | 0.020 |
Why?
|
| Adult Stem Cells | 1 | 2011 | 73 | 0.020 |
Why?
|
| Eukaryota | 1 | 2010 | 27 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1958 | 0.020 |
Why?
|
| Poly A | 1 | 1990 | 88 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2013 | 332 | 0.020 |
Why?
|
| Vagina | 1 | 2012 | 321 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1990 | 211 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 507 | 0.020 |
Why?
|
| Antioxidants | 1 | 2013 | 511 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2011 | 311 | 0.020 |
Why?
|
| Genes, Dominant | 2 | 2004 | 330 | 0.020 |
Why?
|
| Metaphase | 2 | 1993 | 106 | 0.020 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 2 | 2000 | 176 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2011 | 181 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 2288 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1990 | 539 | 0.020 |
Why?
|
| Cesarean Section | 1 | 2012 | 368 | 0.020 |
Why?
|
| Psychophysics | 1 | 2008 | 19 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2011 | 237 | 0.020 |
Why?
|
| Appetitive Behavior | 1 | 2008 | 18 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2009 | 277 | 0.020 |
Why?
|
| Fungi | 1 | 2009 | 146 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2014 | 2605 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 980 | 0.020 |
Why?
|
| Spermatozoa | 2 | 2004 | 311 | 0.020 |
Why?
|
| DNA, Algal | 1 | 2007 | 1 | 0.020 |
Why?
|
| Exploratory Behavior | 1 | 2008 | 106 | 0.020 |
Why?
|
| Oryza | 1 | 2007 | 34 | 0.020 |
Why?
|
| Cell Movement | 1 | 2015 | 2462 | 0.020 |
Why?
|
| Chloroplasts | 1 | 2007 | 15 | 0.020 |
Why?
|
| Leukocytes | 2 | 2004 | 416 | 0.020 |
Why?
|
| Reaction Time | 1 | 2008 | 231 | 0.020 |
Why?
|
| Locomotion | 1 | 2008 | 84 | 0.020 |
Why?
|
| Photosynthesis | 1 | 2007 | 16 | 0.020 |
Why?
|
| Ouabain | 1 | 1987 | 40 | 0.020 |
Why?
|
| Flagella | 1 | 2007 | 39 | 0.020 |
Why?
|
| DNA, Single-Stranded | 3 | 1993 | 106 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 1541 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 1221 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2000 | 566 | 0.020 |
Why?
|
| CELF1 Protein | 1 | 2007 | 46 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 2 | 2005 | 1122 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2005 | 2028 | 0.020 |
Why?
|
| Risk | 1 | 2012 | 1974 | 0.020 |
Why?
|
| Neomycin | 2 | 1984 | 37 | 0.020 |
Why?
|
| Dehydration | 1 | 2007 | 86 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 2325 | 0.020 |
Why?
|
| Kinetics | 1 | 1990 | 2041 | 0.020 |
Why?
|
| Insulin | 1 | 2013 | 1446 | 0.020 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1987 | 132 | 0.020 |
Why?
|
| Arabidopsis | 1 | 2007 | 121 | 0.020 |
Why?
|
| Comorbidity | 1 | 2013 | 2397 | 0.020 |
Why?
|
| Somatosensory Disorders | 1 | 2006 | 6 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 4745 | 0.020 |
Why?
|
| Phosphorylation | 2 | 1995 | 4809 | 0.020 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2006 | 27 | 0.020 |
Why?
|
| DNA Repair | 2 | 2007 | 1870 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2014 | 16213 | 0.020 |
Why?
|
| Ataxin-1 | 2 | 1998 | 147 | 0.020 |
Why?
|
| Synteny | 1 | 2006 | 87 | 0.020 |
Why?
|
| Pseudogenes | 2 | 1997 | 81 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 591 | 0.020 |
Why?
|
| Interferon-Stimulated Gene Factor 3 | 1 | 2005 | 5 | 0.020 |
Why?
|
| Motor Skills | 1 | 2006 | 103 | 0.020 |
Why?
|
| Utah | 1 | 2005 | 43 | 0.020 |
Why?
|
| Replicon | 1 | 2005 | 8 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2005 | 25 | 0.020 |
Why?
|
| Kidney | 1 | 1995 | 2144 | 0.020 |
Why?
|
| Adenosine Deaminase | 1 | 1986 | 94 | 0.020 |
Why?
|
| Genes, MHC Class I | 1 | 2005 | 46 | 0.020 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2005 | 53 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2005 | 62 | 0.020 |
Why?
|
| Telephone | 1 | 2006 | 163 | 0.020 |
Why?
|
| STAT Transcription Factors | 1 | 2005 | 79 | 0.020 |
Why?
|
| Drug Resistance, Viral | 1 | 2005 | 71 | 0.020 |
Why?
|
| Chromosomes, Human, Y | 1 | 2005 | 52 | 0.020 |
Why?
|
| Crossing Over, Genetic | 1 | 2005 | 56 | 0.020 |
Why?
|
| Nerve Fibers | 1 | 2005 | 106 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2007 | 310 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2006 | 230 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 3448 | 0.020 |
Why?
|
| Hospitals, Veterans | 1 | 2007 | 399 | 0.020 |
Why?
|
| Transgenes | 1 | 2006 | 556 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 1066 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 1879 | 0.020 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2005 | 165 | 0.010 |
Why?
|
| Janus Kinases | 1 | 2005 | 174 | 0.010 |
Why?
|
| Drug Stability | 1 | 2004 | 106 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2005 | 623 | 0.010 |
Why?
|
| Models, Neurological | 1 | 2005 | 225 | 0.010 |
Why?
|
| Dogs | 1 | 1986 | 1157 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 328 | 0.010 |
Why?
|
| Neuromuscular Junction | 1 | 2004 | 90 | 0.010 |
Why?
|
| Aging | 2 | 2006 | 1533 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 5378 | 0.010 |
Why?
|
| Mouth Mucosa | 1 | 2004 | 216 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 4338 | 0.010 |
Why?
|
| False Negative Reactions | 2 | 1994 | 274 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 2007 | 621 | 0.010 |
Why?
|
| Liver Neoplasms | 3 | 2005 | 4563 | 0.010 |
Why?
|
| Memory | 1 | 2006 | 430 | 0.010 |
Why?
|
| Disease Transmission, Infectious | 1 | 2004 | 94 | 0.010 |
Why?
|
| False Positive Reactions | 2 | 1994 | 351 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2005 | 485 | 0.010 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1996 | 2781 | 0.010 |
Why?
|
| Neutropenia | 1 | 2007 | 965 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2007 | 1240 | 0.010 |
Why?
|
| Age Distribution | 1 | 2004 | 703 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 2003 | 155 | 0.010 |
Why?
|
| Genes, myc | 1 | 2004 | 358 | 0.010 |
Why?
|
| Hyperkinesis | 1 | 2002 | 23 | 0.010 |
Why?
|
| Germ Cells | 1 | 2004 | 338 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 7566 | 0.010 |
Why?
|
| Maze Learning | 1 | 2002 | 132 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2007 | 847 | 0.010 |
Why?
|
| Gene Order | 1 | 2001 | 111 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2004 | 577 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 1986 | 939 | 0.010 |
Why?
|
| GC Rich Sequence | 1 | 2001 | 7 | 0.010 |
Why?
|
| Public Sector | 1 | 2001 | 11 | 0.010 |
Why?
|
| Private Sector | 1 | 2001 | 33 | 0.010 |
Why?
|
| Meiosis | 1 | 1991 | 166 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2002 | 281 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 2001 | 286 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1994 | 1554 | 0.010 |
Why?
|
| Filamins | 1 | 2000 | 34 | 0.010 |
Why?
|
| Drug Industry | 1 | 2001 | 88 | 0.010 |
Why?
|
| Neuroglia | 1 | 2002 | 224 | 0.010 |
Why?
|
| Heteroduplex Analysis | 1 | 2000 | 6 | 0.010 |
Why?
|
| Euchromatin | 1 | 2000 | 15 | 0.010 |
Why?
|
| Contractile Proteins | 1 | 2000 | 43 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2003 | 437 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 1986 | 1638 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2000 | 94 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 1984 | 862 | 0.010 |
Why?
|
| Heterochromatin | 1 | 2000 | 84 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 2207 | 0.010 |
Why?
|
| beta Catenin | 1 | 2004 | 687 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 21737 | 0.010 |
Why?
|
| Dyskeratosis Congenita | 1 | 1999 | 26 | 0.010 |
Why?
|
| Genes, Insect | 1 | 2000 | 131 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2004 | 1864 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 1990 | 4386 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2005 | 14561 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2000 | 259 | 0.010 |
Why?
|
| Blood Proteins | 1 | 2000 | 292 | 0.010 |
Why?
|
| Fetus | 2 | 1993 | 592 | 0.010 |
Why?
|
| Anxiety | 1 | 2006 | 1188 | 0.010 |
Why?
|
| TATA Box | 1 | 1998 | 36 | 0.010 |
Why?
|
| Mexican Americans | 1 | 2000 | 322 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2004 | 1540 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2000 | 648 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2005 | 1759 | 0.010 |
Why?
|
| Smoking | 1 | 2007 | 2464 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2000 | 573 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1997 | 73 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2000 | 488 | 0.010 |
Why?
|
| Tunisia | 1 | 1997 | 4 | 0.010 |
Why?
|
| Israel | 1 | 1997 | 53 | 0.010 |
Why?
|
| Cricetulus | 2 | 1990 | 204 | 0.010 |
Why?
|
| Arabs | 1 | 1997 | 38 | 0.010 |
Why?
|
| Body Patterning | 1 | 1997 | 213 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 1997 | 205 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2000 | 724 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1998 | 524 | 0.010 |
Why?
|
| Incidence | 1 | 2007 | 5713 | 0.010 |
Why?
|
| Erythroid Precursor Cells | 1 | 1996 | 61 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1998 | 798 | 0.010 |
Why?
|
| Abortion, Habitual | 1 | 1995 | 24 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1995 | 143 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 1995 | 118 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 1998 | 622 | 0.010 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 1995 | 10 | 0.010 |
Why?
|
| Herpes Simplex Virus Protein Vmw65 | 1 | 1995 | 22 | 0.010 |
Why?
|
| Host Cell Factor C1 | 1 | 1995 | 14 | 0.010 |
Why?
|
| Fetal Proteins | 1 | 1995 | 28 | 0.010 |
Why?
|
| DNA, Satellite | 1 | 1994 | 36 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2004 | 2362 | 0.010 |
Why?
|
| Chromatin | 1 | 2000 | 950 | 0.010 |
Why?
|
| Ontario | 1 | 1994 | 97 | 0.010 |
Why?
|
| Minnesota | 1 | 1994 | 100 | 0.010 |
Why?
|
| Interphase | 1 | 1993 | 146 | 0.010 |
Why?
|
| Probability | 1 | 1995 | 868 | 0.010 |
Why?
|
| Macropodidae | 1 | 1992 | 12 | 0.010 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 1993 | 128 | 0.010 |
Why?
|
| Germany | 1 | 1993 | 112 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1993 | 239 | 0.010 |
Why?
|
| Inositol Polyphosphate 5-Phosphatases | 1 | 1992 | 11 | 0.010 |
Why?
|
| Chorionic Villi Sampling | 1 | 1992 | 46 | 0.010 |
Why?
|
| Reference Values | 1 | 1994 | 1096 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 1995 | 417 | 0.010 |
Why?
|
| Axons | 1 | 1995 | 404 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 1997 | 1139 | 0.010 |
Why?
|
| Herpesviridae Infections | 1 | 1993 | 174 | 0.010 |
Why?
|
| Seizures | 1 | 1997 | 986 | 0.010 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1990 | 6 | 0.010 |
Why?
|
| Cattle | 1 | 1992 | 783 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1997 | 3022 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 1992 | 435 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1990 | 625 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 1994 | 1034 | 0.010 |
Why?
|
| Apoptosis | 1 | 2004 | 7601 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1992 | 444 | 0.010 |
Why?
|
| Prevalence | 1 | 1997 | 3272 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 1 | 1993 | 968 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1993 | 2344 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 1997 | 1681 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 1994 | 4976 | 0.000 |
Why?
|
| Sterols | 1 | 1984 | 23 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1984 | 119 | 0.000 |
Why?
|
| Receptors, LDL | 1 | 1984 | 109 | 0.000 |
Why?
|